Research advances in clinical treatment of adult autoimmune hepatitis / 临床肝胆病杂志
Journal of Clinical Hepatology
; (12): 1459-1465, 2021.
Article
em Zh
| WPRIM
| ID: wpr-877338
Biblioteca responsável:
WPRO
ABSTRACT
Autoimmune hepatitis (AIH) is an immune-mediated inflammatory injury of hepatocytes, which can develop into liver cirrhosis and end-stage liver disease. Timely immunosuppressive therapy can help patients achieve biochemical remission and even histological remission and thus improve prognosis. However, adverse drug reactions during treatment and recurrence after withdrawal are commonly seen, and therefore, standard therapy, dose reduction at the right time, and timely drug withdrawal are important for improving patients’ prognosis. This article summarizes the advances in guidelines for the diagnosis and treatment of AIH and related studies in China and globally, so as to provide a reference for clinicians in the treatment of AIH.
Texto completo:
1
Índice:
WPRIM
Tipo de estudo:
Guideline
Idioma:
Zh
Revista:
Journal of Clinical Hepatology
Ano de publicação:
2021
Tipo de documento:
Article